Skip to content

Celcuity CELC PP&E (Net)

PP&E (Net) at other companies

Eli Lilly logo
Eli LillyLLY
$26.54B+43.7%
Gilead Sciences logo
Gilead SciencesGILD
$5.64B+4.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$4.94M-26.2%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$1.22M-76.3%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$5.3M-17.9%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$6.38M-15.4%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's PP&E (net)?
Celcuity (CELC) reported PP&E (net) of $619K in Q1 2026.
How has Celcuity's PP&E (net) changed year-over-year?
Celcuity's PP&E (net) increased by 72.9% year-over-year, from $358K to $619K.
What is the long-term trend for Celcuity's PP&E (net)?
Over 5 years (2020 to 2025), Celcuity's PP&E (net) has grown at a -2.2% compound annual growth rate (CAGR), from $558.88K to $499K.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.